HYGEIA HEALTH (06078) issues a profit warning, expecting a net profit of approximately 140-200 million yuan in 2025, a year-on-year decrease of about 66% to 76%.
Haige Healthcare (06078) announced that the group expects its revenue in 2025 to be approximately RMB 4.0-4.5 billion, a year-on-year decrease of about 9% to 10%; net profit is expected to be about RMB 140-200 million, a year-on-year decrease of about 66% to 76% (mainly affected by goodwill impairment); adjusted net profit is expected to be about RMB 450-490 million, a year-on-year decrease of about 19% to 25%; net cash flow from operating activities is expected to be about RMB 940-1,000 million, a year-on-year increase of about 33% to 41%.
Hygeia Health (06078) announced that the group's revenue is expected to be approximately RMB 4.0-4.5 billion in 2025, a year-on-year decrease of about 9% to 10%; net profit is expected to be approximately RMB 140-200 million, a year-on-year decrease of about 66% to 76% (mainly affected by impairment of goodwill); adjusted net profit is expected to be approximately RMB 450-490 million, a year-on-year decrease of about 19% to 25%; net cash flow from operating activities is expected to be approximately RMB 940-1,000 million, a year-on-year increase of about 33% to 41%.
The announcement stated that the decrease in revenue, net profit, and adjusted net profit under non-international financial reporting standards is mainly due to the impact of industry and macroeconomic factors, as well as the increased expenses for new hospital openings and depreciation costs incurred by the group. In addition to the above factors, the decrease in net profit for the year ended December 31, 2025, is also mainly attributable to the impairment provision for goodwill of Etern Group Ltd. When determining the necessity and amount of such impairment and provision, the company has carefully assessed the group's operational and financial performance as well as the future prospects of its business. The actual amount of impairment and provision is subject to further evaluation by the company.
Related Articles

On January 30, SHOUHUI GROUP (02621) spent 106,100 Hong Kong dollars to repurchase 30,000 shares.

Selected A-share Announcement | Cambricon (688256.SH) is expected to have a net profit of approximately 1.8 to 2.1 billion yuan last year, turning losses into profits on a year-on-year basis.

Huarong Bio-(02396) appoints Zhang Liting as Joint Company Secretary.
On January 30, SHOUHUI GROUP (02621) spent 106,100 Hong Kong dollars to repurchase 30,000 shares.

Selected A-share Announcement | Cambricon (688256.SH) is expected to have a net profit of approximately 1.8 to 2.1 billion yuan last year, turning losses into profits on a year-on-year basis.

Huarong Bio-(02396) appoints Zhang Liting as Joint Company Secretary.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


